Integrative Multi-Omics and Drug–Response Characterization of Patient-Derived Prostate Cancer Primary Cells

Scientists established 35 Chinese prostate cancer (PCa) primary cell models to capture specific characteristics among PCa patients, including gene mutations, mRNA/protein/surface protein distributions, and pharmaceutical responses.